Stocks
Alnylam Pharmaceuticals, Inc.ALNY
NASDAQHealthcareBiotechnology$313.41-1.20%
A biotechnology company focused on developing RNA interference (RNAi) therapeutics that silence disease-causing genes. Its approved drugs target rare genetic conditions, including hereditary transthyretin-mediated amyloidosis, while a broader pipeline spans cardiometabolic, hepatic, and neurologic d...
Market Cap: $41.6B52W Range: $205.87 – $495.55
Congressional Interest in Alnylam Pharmaceuticals, Inc. (ALNY)
6 members of Congress have disclosed 20 trades in Alnylam Pharmaceuticals, Inc. (ALNY), a Healthcare company. The buy/sell breakdown shows 10 purchases versus 10 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
20
Unique Politicians
6
Buys
10
Sells
10
Who in Congress Is Trading ALNY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-12 | Jefferson Shreve | sell | $15K – $50K |
| 2024-05-14 | MICHAEL T. MCCAUL | buy | $1K – $15K |